BIOTECH TARGET N V - 19 Oct 2022 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role: 10%+ Owner
Signature: /s/Daniel Koller
Issuer symbol: MGNX
Transactions as of: 19 Oct 2022
Net transactions value: +$1,767,484
Form type: 4
Filing time: 21 Oct 2022, 15:03:06 UTC
Previous filing: 30 Aug 2022
Next filing: 25 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MGNX	Common Stock	Purchase	$623,919	+168,422	+2.3%	$3.70	7,443,986	19 Oct 2022	Direct
transaction	MGNX	Common Stock	Purchase	$1,143,565	+285,977	+3.8%	$4.00	7,729,963	20 Oct 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Macrogenics, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.